Document Type
Blog Post
Publication Date
4-25-2021
Disciplines
Nervous System Diseases
Digital USD Citation
Serbin, Kenneth P., "With PROOF-HD in the lead, the Huntington’s disease drug pipeline is still 'full of hope' (Coping with disappointing clinical trial results – Part II)" (2021). At Risk for Huntington's Disease. 303.
https://digital.sandiego.edu/huntingtons/303
